Yes, bempedoic acid, marketed under the brand name Nexletol, is FDA approved. The U.S. Food and Drug Administration (FDA) approved bempedoic acid on February 21, 2020. This medication offers a novel approach to lowering cholesterol levels and reducing the risk of heart-related events for adults with certain conditions.
Bempedoic acid is an oral tablet used to manage high cholesterol levels. It is specifically indicated for:
Bempedoic acid works by inhibiting an enzyme called adenosine triphosphate-citrate lyase (ACL), which plays a crucial role in cholesterol production in the liver.
Bempedoic acid is available as Nexletol, in the form of 180 mg oral tablets. The recommended dosage is one tablet per day, which can be taken with or without food. It is typically used in conjunction with dietary changes and possibly other cholesterol-lowering medications.
While bempedoic acid is generally well tolerated, it can cause some side effects, including:
Serious Side Effects
Bempedoic acid may cause serious side effects such as:
Before taking bempedoic acid, it is essential to inform your healthcare provider of any medical conditions, especially if you have a history of gout, tendon problems, severe kidney or liver issues, or if you are pregnant or breastfeeding.
Bempedoic acid (Nexletol) is a valuable FDA-approved option for individuals needing additional cholesterol management and risk reduction for heart disease, especially for those who are unable to take statins. Approved on February 21, 2020, it provides an effective solution for lowering LDL cholesterol levels and helping to prevent heart attacks and other heart procedures.
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!